Japanese Stock News

Kioxia Holdings (TSE:285A) is back in focus after reporting third quarter earnings with higher sales and net income year on year, along with fresh guidance and commentary tied to NAND memory demand. See our latest analysis for Kioxia Holdings. The latest earnings update and guidance arrived alongside very strong recent momentum, with a 1 day share price return of 7.75% and a 30 day share price return of 71.8%. The 1 year total shareholder return is extremely high, suggesting sentiment around...

Tokyo Electron recently announced a share repurchase program of up to 7,500,000 shares for ¥150,000 million and raised its full-year earnings and dividend guidance for the fiscal year ending March 31, 2026. The combination of higher profit and dividend forecasts, alongside a new buyback, signals management’s confidence in cash generation and mid- to long-term profit potential. We’ll now examine how Tokyo Electron’s upgraded earnings outlook and enhanced shareholder returns reshape its...

Rakuten Bank, Ltd. reported past earnings for the nine months ended December 31, 2025, with net interest income rising to ¥102,843 million and net income increasing to ¥53,119 million, driving higher basic and diluted earnings per share year on year. Alongside this strong interim performance, Rakuten Bank raised its full-year earnings forecast while still opting to pay no dividends to prioritize capital retention and business expansion. We will now examine how Rakuten Bank’s upgraded...

Hikari Tsushin (TSE:9435) has just posted its Q3 2026 update, with recent quarterly revenue running at about ¥194.5 billion in Q2 2026 and basic EPS of ¥960.21, against a backdrop where trailing 12 month EPS sat at ¥3,182.21 on revenue of roughly ¥722.5 billion. Over the past reported quarters, the company has seen revenue move from ¥173.0 billion in Q3 2025 to ¥187.7 billion in Q4 2025 and then to ¥194.5 billion in Q2 2026, while quarterly EPS shifted from ¥1,244.00 in Q3 2025 to ¥336.01 in...

In February 2026, Shimadzu Corporation revised its full-year guidance, lifting expected net sales to ¥555,000 million while keeping operating profit and profit attributable to owners of parent unchanged, and simultaneously reported nine-month results showing higher sales and net income than a year earlier. An interesting angle is that Shimadzu attributes the stronger sales outlook mainly to yen depreciation, yet is choosing to reinvest the incremental benefit into M&A, R&D, and other...

As global markets experience volatility driven by mixed economic signals and sector rotations, investors are increasingly seeking stability through dividend stocks. In this dynamic environment, selecting dividend stocks with strong fundamentals and consistent payout histories can offer a reliable income stream while enhancing portfolio resilience.

Lasertec Corporation reported half-year results to December 31, 2025, with sales of ¥128,258 million and net income of ¥45,745 million, alongside announcing a second-quarter dividend increase to ¥132.00 per share from ¥115.00 a year earlier, payable on March 12, 2026. The company also raised its full-year fiscal 2026 guidance, citing earlier customer acceptance of products and a revised yen/US$ exchange rate assumption of ¥145 per US$ compared with ¥135 previously. We will examine how...

What the latest earnings, guidance and dividend signal for investors FUJIFILM Holdings (TSE:4901) has given investors a fresh information set, combining third quarter and nine month earnings, new full year guidance for fiscal 2026, and an affirmed year end dividend outlook. The company reported third quarter sales of ¥857,354 million and net income of ¥73,143 million, alongside nine month sales of ¥2,429,717 million and net income of ¥193,375 million, each higher than the comparable period a...

Why the Myrbetriq legal settlement matters for Astellas shareholders Astellas Pharma (TSE:4503) has just closed its U.S. patent disputes over overactive bladder drug Myrbetriq, securing settlement and upfront licensing payments from Lupin and Zydus, as well as ongoing per unit fees. For you as an investor, this combination of cash inflows and reduced legal uncertainty can influence how you view the earnings profile tied to Myrbetriq and its generic competition in the U.S. market. See our...

It's been a good week for Marui Group Co., Ltd. ( TSE:8252 ) shareholders, because the company has just released its...

Tosoh Corporation's ( TSE:4042 ) investors are due to receive a payment of ¥50.00 per share on 5th of June. This makes...

Investors in TOC Co., Ltd. ( TSE:8841 ) had a good week, as its shares rose 2.5% to close at JP¥867 following the...

The subdued market reaction suggests that Toyota Motor Corporation's ( TSE:7203 ) recent earnings didn't contain any...

Sanrio Company (TSE:8136) has put investors on alert after a February 12 board meeting combined three shareholder focused moves: an upcoming stock split, higher full year earnings guidance, and an increased dividend forecast. See our latest analysis for Sanrio Company. Despite Sanrio’s stronger guidance and dividend outlook, the share price is currently ¥4,764, with a 3 month share price return of an 18% decline and a 1 year total shareholder return of a 22% decline, while the 5 year total...

Sekisui Chemical has now completed its previously announced share repurchase plan, buying back 10,000,000 shares (2.43% of shares) for ¥26,420.48 million by February 9, 2026. This completed buyback reduces the share count and may enhance per-share metrics, underlining management’s willingness to return capital to investors. Next, we’ll examine how the completion of this sizeable buyback program may influence Sekisui Chemical’s existing investment narrative. We've uncovered the 14 dividend...

Takeda Pharmaceutical (TSE:4502) just cleared two meaningful milestones, with the U.S. FDA granting Priority Review for its narcolepsy type 1 candidate oveporexton and a new AI-focused drug discovery collaboration with Iambic. See our latest analysis for Takeda Pharmaceutical. The recent regulatory progress for oveporexton and the AI drug discovery partnership with Iambic come as Takeda’s shares trade at ¥5,609, with a 30-day share price return of 11.73%, a 90-day share price return of...

When companies post strong earnings, the stock generally performs well, just like Ricoh Company, Ltd.'s ( TSE:7752...

The Nomura Research Institute, Ltd. ( TSE:4307 ) share price has fared very poorly over the last month, falling by a...

Honda Motor Co., Ltd. ( TSE:7267 ) investors will be delighted, with the company turning in some strong numbers with...

The board of Sumitomo Mitsui Financial Group, Inc. ( TSE:8316 ) has announced that it will be paying its dividend of...

Investors in Yakult Honsha Co.,Ltd. ( TSE:2267 ) had a good week, as its shares rose 2.1% to close at JP¥2,662...

SoftBank Corp. has reported past earnings for the nine months ended December 31, 2025, with sales of ¥5.20 trillion and net income of ¥485.52 billion, both higher than the previous year. The improvement in basic and diluted earnings per share from continuing operations suggests greater profit generation per share, which may influence how investors assess SoftBank’s earnings power. We’ll now examine how this growth in sales and net income shapes SoftBank’s broader investment narrative and...

SMC Corporation ( TSE:6273 ) will pay a dividend of ¥500.00 on the 30th of June. The dividend yield is 1.4% based on...

Shareholders will be ecstatic, with their stake up 25% over the past week following Fuji Corporation 's ( TSE:6134...